|
Author Question: Marketing research can help prevent the commercialization of products that are not ... (Read 64 times) |
The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.
Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.
Women are 50% to 75% more likely than men to experience an adverse drug reaction.
The average human gut is home to perhaps 500 to 1,000 different species of bacteria.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.